Insulin (Iv) Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) solution

Available Strengths: 100 units/mL (U-100) in 10 mL vials

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

Category: Critical Care

IV Insulin (Regular) is essential for critical care glucose control, available as 100 units/mL in 10 mL vials. Trusted brands like Humulin® R and Actrapid® offer fast-acting relief. Pharma B2B platforms supply GMP-grade insulin in bulk, ensuring hospital-ready quality, compliance, and reliable global distribution. Insulin (IV) is available in Intravenous (IV) solution and strengths such as 100 units/mL (U-100) in 10 mL vials. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Insulin (IV) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Insulin (IV) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: IV Insulin, primarily Regular (short-acting) insulin, is vital in managing diabetic ketoacidosis, hyperkalemia, and perioperative glycemic control. Administered intravenously in hospital settings, it is available as a 100 units/mL solution in 10 mL vials. Key brands include Humulin® R, Novolin® R in the US, and Actrapid®, Insuman® Rapid in the EU. This formulation allows rapid onset and precise control of blood glucose. Pharma B2B platforms facilitate bulk procurement of IV Insulin from GMP-certified manufacturers, ensuring hospital-grade quality, consistent supply, and global regulatory compliance for ICUs, emergency departments, and critical care environments.